Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy

Journal of Hypertension

Volumn 13, Issue , 1995, Pages S91-S93

  Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium antagonists; Diabetes mellitus; Diabetic nephropathy; Hypertension; Microalbuminuria; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEINURIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TESTS; REGIONAL BLOOD FLOW;

EID: 0029149354     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199508001-00015     Document Type: Article

References (26)

1. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 1985, 78:785-794.
2. Schmiz A: The kidney in non-insulin-dependent diabetes: studies on glomerular structure and function and the relationship between microalbuminuria and mortality. Acta Diabetol 1993, 29:47-69.
3. Eggers PW, Connerton R, McMullan M: The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Finance Rev 1984, 5:69-88.
4. Borch-Johnsen K: The prognosis of insulin-dependent diabetes mellitus: an epidemiological approach. Dan Med Bull 1989, 36:336-348.
5. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40 year follow-up study. Diabetes Care 1986, 9:443-452.
6. Borch-Johnsen K, Kreiner S: Proteinuria value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987, 294:1651-1654.
7. Hostetter TH: Diabetic nephropathy. In The Kidney. Edited by Brenner BM, Rector FC. Philadelphia: WB Saunders; 1991:1695-1727.
8. Earle K, Viberti CC: Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int 1994, 45:434-437.
9. Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, et al.: Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992, 41:829-835.
10. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Laakso M: Microalbuminuria precedes the development of non-insulin- dependent diabetes mellitus. Diabetes 1994, 43:552-557.
11. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl I Med 1993, 329:977-986.
12. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al., for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994, 330:877-884.
13. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR: Effect of restricting dietary proteins on the progression of renal failure patients with insulin-dependent diabetes mellitus. N Engl J Med 1991, 324:78-84.
14. Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976, 36:383-388.
15. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M: Proteinuria, renal impairment, metabolic control, and blood pressure in type II diabetes mellitus. Arch Intern Med 1992, 152:1225-1229.
16. Parving HH, Andersen AR, Smidt UM, Homel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 1987, 294:1443-1447.
17. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T: Improved survival in patients with diabetic nephropathy. Dia- betologia 1989, 32:884-886.
18. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994, 45:402-410.
19. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982, 72:375-380.
20. Viberti GC, Mogensen CE, Groop LC, Pauis JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin- dependent diabetes mellitus. JAMA 1994, 271:275-279.
21. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Longterm stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993, 118:577-581.
22. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
23. Rossing P, Hommel, Smidt UM, Parving HH: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 1994, 45 (suppl 45): S145-SI49.
24. Praga M, Heranandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992, 20:240-248.
25. Ruilope LM, Casal MC, Praga M, Alcazar JM, Decap G, Lahera V, et al.: Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol 1992, 3:1307-1311.
26. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992, 41:912-919.